The Conceptual Independence of Health Status, Respiratory Symptoms and Dyspnea in Chronic Obstructive Pulmonary Disease in Real Clinical Practice

The hypothesis that health status is the highest ranking concept, followed by respiratory symptoms and dyspnea as the lowest ranking concepts in subjects with chronic obstructive pulmonary disease (COPD) was tested in a real clinical setting with 157 subjects with stable COPD. Spearman’s rank correlation coefficients for scores of health status using the COPD Assessment Test (CAT), respiratory symptoms using the COPD Evaluating Respiratory Symptoms (E-RS) and dyspnea using Dyspnea-12 (D-12) between any two were 0.6 to 0.7. Upon categorizing the patients as “abnormal” or “normal” according to the threshold, it was found that 30 patients (19.1%) had dyspnea, respiratory symptoms and impaired health status. Dyspnea was considered an important part of respiratory symptoms, though seven patients had dyspnea but no respiratory symptoms. There were 10 patients who had respiratory symptoms without dyspnea but without health status problems. Furthermore, there were six patients who had both dyspnea and respiratory symptoms but whose health status was classified as fine. Thus, the hypothesis was correct in approximately 85% of cases.

[1]  M. Bayraktaroglu,et al.  How to Utilize CAT and mMRC Scores to Assess Symptom Status of Patients with COPD in Clinical Practice? , 2022, Medeniyet medical journal.

[2]  H. Taniguchi,et al.  Comparison between tools for measuring breathlessness: Cross‐sectional validation of the Japanese version of the Dyspnoea‐12 , 2021, The clinical respiratory journal.

[3]  R. Jiménez-García,et al.  Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity , 2020, International journal of chronic obstructive pulmonary disease.

[4]  Y. Hasegawa,et al.  How different are COPD-specific patient reported outcomes, health status, dyspnoea and respiratory symptoms? An observational study in a working population , 2019, BMJ Open.

[5]  R. Mittal,et al.  GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment , 2017, COPD.

[6]  B. Kollen,et al.  Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George’s Respiratory Questionnaire cutoff 25 (and 20) as reference , 2016, International journal of chronic obstructive pulmonary disease.

[7]  K. Larsson,et al.  Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use? , 2016, Expert review of respiratory medicine.

[8]  Jin H. Lee,et al.  Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD , 2015, International journal of chronic obstructive pulmonary disease.

[9]  J. Soriano,et al.  Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD. , 2015, Chest.

[10]  J. Yorke,et al.  The assessment of breathlessness in pulmonary arterial hypertension: Reliability and validity of the Dyspnoea-12 , 2014, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[11]  N. Leidy,et al.  Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials , 2014, Respiratory Research.

[12]  J. Bourbeau,et al.  Derivation of normative data for the COPD assessment test (CAT) , 2014, Respiratory Research.

[13]  P. Jones,et al.  Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary , 2014, Thorax.

[14]  Y. Hasegawa,et al.  COPD and disease-specific health status in a working population , 2013, Respiratory Research.

[15]  S. Wyke,et al.  Patient-Reported Outcome Measures for Chronic Obstructive Pulmonary Disease , 2013, The Patient - Patient-Centered Outcomes Research.

[16]  P. Jones,et al.  Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification , 2012, European Respiratory Journal.

[17]  T. Kawayama,et al.  Development of the Japanese version of the COPD Assessment Test. , 2012, Respiratory investigation.

[18]  P. Jones,et al.  Creating scenarios of the impact of copd and their relationship to copd assessment test (CAT™) scores , 2011, BMC pulmonary medicine.

[19]  P. Kardos,et al.  Properties of the COPD assessment test in a cross-sectional European study , 2011, European Respiratory Journal.

[20]  N. Leidy,et al.  Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. , 2011, American journal of respiratory and critical care medicine.

[21]  N. Leidy,et al.  Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[22]  P. Jones,et al.  Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12 , 2009, Thorax.

[23]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[24]  N. Leidy,et al.  Improving the process and outcome of care in COPD: development of a standardised assessment tool. , 2009, Primary care respiratory journal : journal of the General Practice Airways Group.

[25]  M. Tsukino,et al.  Comparison of Health-Related Quality of Life Measurements Using a Single Value in Patients with Asthma and Chronic Obstructive Pulmonary Disease , 2008, The Journal of asthma : official journal of the Association for the Care of Asthma.

[26]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[27]  M. Tsukino,et al.  Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[28]  M. Hyland,et al.  Development of a new type of global quality of life scale, and comparison of performance and preference for 12 global scales , 1996, Quality of Life Research.

[29]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[30]  L. Hang,et al.  Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

[31]  A. Russell,et al.  Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. , 2011, Chest.

[32]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.